Rubella surveillance no. 2, AUGUST 1970
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields



Publication Date Range:


Document Data


Document Type:






Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page


Rubella surveillance no. 2, AUGUST 1970

Filetype[PDF-10.37 MB]

Select the Download button to view the document
This document is over 5mb in size and cannot be previewed
  • English

  • Details:

    • Description:
      In June 1969, a live attenuated rubella virus vaccine was licensed for use in the United States. Subsequently, two other rubella vaccines have been licensed. Thus, rubella vaccine has become available 28 years after the recognition of the etiologic relationship between rubella and congenital rubella syndrome in 1941, 7 years after the isolation of rubella virus in 1962, and 4 years after the first reports of the attenuation of rubella virus. Because considerable experience with these vaccines has accumulated since licensure, it is appropriate to review the available surveillance data.
    • Content Notes:
      I. Introduction -- II. Recent Trends: A. Source of Data; B. Reported Rubella -- III. Congenital Rubella Syndrome Surveillance -- IV. Biologic Surveillance -- V. Reported Reactions Associated with Administration of Rubella Vaccine: A. Joint reactions; B. Neurological reactions temporally associated with administratin of rubella vaccine. -- VI. Appendix A. Congenital Rubella Syndrome Case Report Form; Appendix B. Serologic Assistance in Rubella Diagnosis; Appendix C. Availability of Rubella Serologic Testing; Appendix D. Recommendations for Use of Rubella Virus Vaacine ; Appendix E. Serologic Testing for Rubella--A warning.
    • Document Type:
    • Place as Subject:
    • Main Document Checksum:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    You May Also Like

    Checkout today's featured content at